ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,732.93
0.25%
US Tech 100
19,430.00
0.56%
Dow Jones
42,208.22
0.20%
Brent Oil
74.56
1.12%
Bitcoin
64,278.42
1.50%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. BNP Paribas (BNP) Quote

BNP Paribas

BNP Paribas (BNP)

Danone
Danone
Danone
Danone
BNP Paribas
62.82
0.41
(0.66%)
Closed September 24 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
62.82
Bid
62.76
Ask
63.42
Volume
1,969,233
62.69 Day's Range 63.52
52.82 52 Week Range 73.08
Market Cap
77.495B
Previous Close
62.41
Open
62.89
Last Trade
12
@
62.82
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,202,079
Shares Outstanding
1,233,609,675
Dividend Yield
7.32%
PE Ratio
7.06
Earnings Per Share (EPS)
8.9
Revenue
57.98B
Net Profit
10.98B

About BNP Paribas

Sector
Commercial Banks, Nec
Industry
Commercial Banks, Nec
Website
group.bnpparibas
Headquarters
Paris, Paris, Fra
Founded
-
BNP Paribas is listed in the Commercial Banks sector of the Euronext with ticker BNP. The last closing price for BNP Paribas was 62.41 €. Over the last year, BNP Paribas shares have traded in a share price range of 52.82 € to 73.08 €.

BNP Paribas currently has 1,233,609,675 shares outstanding. The market capitalization of BNP Paribas is 76.99 € billion. BNP Paribas has a price to earnings ratio (PE ratio) of 7.06.

Ask ADVFN Intelligence (AI)

BNP Latest News

More News

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - août 2024

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - août 2024 Raison sociale de l'émetteur : BNP PARIBAS - SA au capital de 2.261.621.342 euros Immatriculée sous le n° 662 042 449...

September 05 2024
UK Regulatory

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - juillet 2024

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - juillet 2024 Raison sociale de l'émetteur : BNP PARIBAS - SA au capital de 2.261.621.342 euros Immatriculée sous le n° 662 042 449...

August 05 2024
UK Regulatory

GROUPE BNP PARIBAS : Mise à disposition du 2ème amendement au Document d’enregistrement universel et rapport financier annuel 2023

GROUPE BNP PARIBAS : Mise à disposition du 2ème amendement au Document d’enregistrement universel et rapport financier annuel 2023 Mise à disposition du 2ème amendement au Document...

August 02 2024
UK Regulatory

GROUPE BNP PARIBAS : Release of the second amendment to the Universal registration document and annual financial report 2023

GROUPE BNP PARIBAS : Release of the second amendment to the Universal registration document and annual financial report 2023 Release of the second amendment to the Universal registration document...

August 02 2024
UK Regulatory

BNP Paribas : Exclusive negotiation with Axa for the acquisition of Axa Investment Managers and a long-term partnership in asset management

BNP Paribas : Exclusive negotiation with Axa for the acquisition of Axa Investment Managers and a long-term partnership in asset management BNP PARIBAS ENTERS INTO EXCLUSIVE NEGOTIATIONS WITH AXA...

August 01 2024
UK Regulatory

BNP Paribas: Négociations exclusives avec Axa en vue de l’acquisition d’Axa Investment Managers et d’un partenariat de long terme dans la gestion d’actifs

BNP Paribas: Négociations exclusives avec Axa en vue de l’acquisition d’Axa Investment Managers et d’un partenariat de long terme dans la gestion d’actifs BNP PARIBAS ENTRE EN NEGOCIATIONS...

August 01 2024
UK Regulatory

COMP Drops Following Controversial Proposal Approval, ETH Achieves Historic Gas Fee Reduction, Ava Labs VP Resigns

Controversy at Compound Finance after DeFi proposal approval Compound Finance’s native token (COIN:COMPUSD), a notable decentralized finance (DeFi) protocol, is declining following a...

July 29 2024
IH Market News

US Index Futures Fall Amid Tech Giant Earnings, Oil Prices Rise

U.S. index futures fell in pre-market trading on Wednesday, impacted by recent financial results from tech giants Tesla and Alphabet. Investors are watching for potential Federal Reserve interest...

July 24 2024
IH Market News

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - juin 2024

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - juin 2024 Raison sociale de l'émetteur : BNP PARIBAS - SA au capital de 2.261.621.342 euros Immatriculée sous le n° 662 042...

July 08 2024
GlobeNewswire Inc.

U.S. Index Futures Slightly Rise in Pre-Market Trading, Set for Weekly Gains

U.S. index futures show a slight increase in pre-market trading this Friday, with indices on track to end the week with gains as investors eagerly await payroll data. At 06:21 AM, Dow Jones...

July 05 2024
IH Market News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.87-1.3659915214363.6965.661.51286819564.09416546DE
41.432.3293696041761.3965.660.54204936963.10380407DE
121.612.6302891684461.2165.655.84220207962.13713DE
260.10.1594387755162.7273.0855.84258562763.64252033DE
522.243.6975899636860.5873.0852.82260826060.99691858DE
1565.7210.017513134957.173.0840.665313640356.35651531DE
26018.6442.191036668244.1873.0824.505367806149.15245909DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
13.38M
ALINSIntrasense
0.40 €
(36.52%)
1.6M
ALKLHKlea Holdings
0.2355 €
(23.95%)
10.83M
SCHDScheerders van Kerchoves Verenigde Fabrieken
320.00 €
(23.08%)
11
ALWTROsmosun SA
3.80 €
(19.31%)
39.23k
ALAGOEPango SA
0.097 €
(-42.67%)
5.47M
MLGALGaleo Concept
1.20 €
(-31.43%)
485
ALDNEDONTNOD Entertainment SA
1.425 €
(-18.57%)
173.62k
MLSUMSumo Resourcs Plc
0.0045 €
(-18.18%)
386.43k
ALSPWSpineway
0.269 €
(-17.99%)
259.42k
BCPBanco Comercial Portugues SA
0.4063 €
(-0.61%)
47.38M
LOCALSolocal Groupe
0.0029 €
(0.00%)
17.05M
ALDRVDrone Volt
0.0044 €
(-2.22%)
13.98M
ALCYBCybergun
0.0002 €
(100.00%)
13.38M
ALAVEAventador
0.0036 €
(-5.26%)
13.23M

Discussion

View Full Feed
The Night Stalker The Night Stalker 21 seconds ago
nice
AZRH
boi568 boi568 23 seconds ago
Perhaps Anavex was waiting for this before starting its PD trial.
AVXL
Just the facts maam Just the facts maam 1 minute ago
Good list Silvr, obviously they won't provide PDUFA dates, with name of drug and indications or naming their partner.

If ANIP is not bought out directly, I believe many of the items you have listed get addressed once the partnership is announced.
ANIP
LTListener LTListener 2 minutes ago
I believe the company keeps otcmarkets up to date.
RSPI
oilsleuth oilsleuth 2 minutes ago
It takes six mods to keep the board a safe space for the faithful few. Some rude sods might say the company isn't doing very well if the mods weren't constantly on the alert.
RMHB
PEACHMAN PEACHMAN 4 minutes ago
Here is a paragraph from the article The IFUS tweet talked about testing that showed flies left after SGP+ was fed and flies and smell returned when cattle during new test were taken off SGP+.

The article show the $850 million dollars that cattle ranchers spend due to flies..Using SGP
IFUS
The Night Stalker The Night Stalker 4 minutes ago
https://www.stockscores.com/charts/charts/?ticker=sinc
SINC
ChannelTrader ChannelTrader 5 minutes ago
I thought the same and his last name crazybull indicates very possible.
Cashman17 Cashman17 5 minutes ago
Did u ask him why the company he went completely dark no social media no prs nothing in the past 8 months ?
EGYF
facts_matter14 facts_matter14 7 minutes ago
WOW! $36.00 volume today! Can’t wait for that next trade show!!!







.
SRMX
DP1011 DP1011 7 minutes ago
Just another day of massive sell offs. Nothing to see here.
PHIL
vuletini vuletini 8 minutes ago
Just like Kamala you have strong beliefs....ding ding ding
XRPUSD
Rolex666 Rolex666 8 minutes ago
Well over 300k$ just in the last 3 years, not counting the new money he has been raising for his imaginary friend in 2024 ….another 10k or so
ERHE
cadillacdave cadillacdave 8 minutes ago
Also, a lot of the ultra-rich say they are leaving their fortune to charity, to get a pass from those who criticize them. They all say they are willing to pay more taxes, but then take steps to avoid doing so.

In most cases, as the end draws closer for the ultra-rich, they generally
NVDA
againstallodds againstallodds 9 minutes ago
GNCP is Expert Market Sunshine

Ticker shows NO PULSE
GNCP
go seek go seek 9 minutes ago
alert, you ask questions which are impossible to answer. Suggest you wait till after the chickens are hatched, before counting ‘em. Best wishes.
ENTA
Awl416 Awl416 9 minutes ago
Vertex Energy and Its Lenders Initiate Formal Pathway Aimed at Achieving Sustainable Capital Structure
VTNR
The Night Stalker The Night Stalker 9 minutes ago
OS goes up by day, events to look forward to the day
SINC
Aimless Blade Aimless Blade 10 minutes ago
Today was a good day !
(Yesterday was pretty good, too…)

How anyone could be down on this company is beyond me.
The progress, the position, the prototypes!

Nowhere to go but up!
Get those shares before they go over $5 again.
LWLG
TechandBio TechandBio 11 minutes ago
Hilarious listening to the boards about how awful the executive team was in the $2.00 area last year now they are the toast of the town.

$CAPR
CAPR
Talon38 Talon38 11 minutes ago
Via MJFF, a new more focused plan for Parkinson's from their work with the FDA. Will it help AVXL?

https://www.michaeljfox.org/news/fda-encourages-use-parkinsons-biomarker-future-clinical-trials?em_cid=mc-a1bVL000002LLrV
AVXL
HRAJA11102 HRAJA11102 11 minutes ago
I am surprised this is still holding up the way it is even with the another set of missed deadlines.
BMXI
djjazzyjeff djjazzyjeff 11 minutes ago
Simply put leronlimab is no better than the drug already approved. It's over.
CYDY
WebSlinger WebSlinger 11 minutes ago
Great post....

>

It is pretty simple.... They have no commercial product and no revenue....

https://www.insightaceanalytic.com/images_data/618868418.JPG
KBLB
TechandBio TechandBio 12 minutes ago
TSLA 300.00 Target first Target!
MSTR and IceCure ICCM accumulating!
ICCM MSTR TSLA

Your Recent History

EU
BNP
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved